No Detail Found!

Estrogen replacement therapy for depression in perimenopausal women

Author(s)
Asma Shaukat Department of Pathology, Quaid-i-Azam Medical College, Bahawalpur, Pakistan.
Tariq Mahmud Arain Department of Ophthalmology, Bahawal Victoria Hospital, Bahawalpur, Pakistan.
Amna Shahid Department of Obstetrics and Gynaecology, Bahawal Victoria Hospital, Bahawalpur, Pakistan.
Shahid Irfan Medical Ward, Bahawal Victoria Hospital, Bahawalpur, Pakistan.
Soufia Farrukh Eye Ward, Bahawal Victoria Hospital, Bahawalpur, Pakistan.
Abstract
Objective: To determine the effect of a four-week course of oral estrogen therapy on depression in aging women. Design: Quasi experimental. Place and Duration of Study: The OPD, Bahawal Victoria Hospital, Bahawalpur, from September 2000 to January 2004. Patients and Methods: Forty-two depressed women (aged 42-57) who were either perimenopausal (n=20) or postmenopausal (n=22) received open label treatment with oral estrogen tablets(1.25mg/day) for 4 weeks. The Montgomery-Asberg Depression Rating Scale and the Beck Depression Inventory were used to assess depressive symptoms, the Greene Climacteric Scale was used to assess menopause-related symptoms, and the Clinical Global Impression(CGI) was used to assess global clinical improvement in these women at baseline and after treatment. Remission of depression was defined as a score <10 on the Montgomery-Asberg Depression Rating Scale and a score < 2 on the CGI at week 4. Results: The women who completed the study had a median Montgomery-Asberg Depression Rating Scale score of 20 (range= 15-32) at study entry and 11.50 (range= 10-31.0) at week 4 (z = -3.43, p<0.01). This improvement was consistent with that reported by the women themselves on the Beck Depression Inventory (rs=0.86, n=20, p<0.01). The improvement measured by CGI scores was also significant (p<0.01). • Remission of depression was noted in 5 of the 40 women (after 1 year) who completed the study. Anti-depressant response was not associated with severity or subtypes of depression at study entry or with concomitant improvement in menopause-related symptoms. Conclusion: Perimenopausal and postmenopausal women benefit from short-term use of estrogen therapy. Antidepressant effect of estrogen therapy is independent of improvement in menopause-related symptoms.
Publication Details
Page(s) 597-600
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 15, Issue: 10, Year: 2005

Request the full text from PASTIC

Keywords
Menopause. Estrogen therapy. Depression.
References
Assoc .1994 .. , : .
.1993 .. J Clin Psychiatry, 54 : 405-18.
Chan BK . .. The economic 18. LeBlancES, : .
.1997 .The physiologicr majorpathologay:5-yearprospectfivoellow-uopf431 subjects. BjorntoPr.pStresasndcardiovascduilsaerasAec.ta Physiol Scand Suppl, 640 : 144-8.
. .. , 62 : 7-6.
.1998 .Depressivseymptom sin the perimenopausper:evalencea,ssessmenta,nd guideline sfor treatmenHatr. v Rev Psychiatry, 6 : 121-32.
But MA .2000 .Effectsof estradioanld progesteroandmeinistrat humanserotin2inA receptobirnding:a PET study. Biol Psychic, 48 : 854-60.
Fu M .2003 .Increasein prefrontcaolrtesxerotin2inA rece followinegstrogetnreatmenintpostmenopauswaolmen. Ai Psychiatry, 160 : 1522-4.
.2001 .Placeboresponsine depressiobna:neof rese boontotherapyB. rJ Psychiatry, 178 : 192-4.
Tobin MB,Roca( MurphyJ. Estrogenreplacemenint MB .2000 .. JObstet Gynaecol, 1 : 414-20.
.2001 .Efficacyofestr forthe treatmenotf depressivedisorderisn perimeno women:a double-blinrda,ndomizedp. Gen Psychiatry, 58 : 529-34.
.2002 .Estrogeannd moodin agingwomen:an updat a justificati ofonrfurthesrtudyA. A4 GP, 148 : 844-52.
Grady D,Khan S .2000 .132: dimericinhibins during the menopausatlransitioi population-bacsoedhorotfwomenJ. Clin EndocrinnolMetahol, : 689-96.
. .Moodvariatio ninselderlwyomen. WashingtoDnC: Am Psychiat 27. SalmanM, 84 : 4025-30.
0

Citations

0

Downloads

29

Views